| 18.51 -0.79 (-4.09%) | 09-21 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 24.69  |
1-year : | 26.67 |
| Resists | First : | 21.14 |
Second : | 22.83 |
| Pivot price | 20.51 |
|||
| Supports | First : | 18.4 |
Second : | 15.31 |
| MAs | MA(5) : | 19.2 |
MA(20) : | 20.65 |
| MA(100) : | 22.4 |
MA(250) : | 27.06 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 8.9 |
D(3) : | 10.4 |
| RSI | RSI(14): 38.5 |
|||
| 52-week | High : | 39.99 | Low : | 16.66 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PRCT ] has closed above bottom band by 5.3%. Bollinger Bands are 12.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 18.93 - 19.06 | 19.06 - 19.17 |
| Low: | 18.17 - 18.29 | 18.29 - 18.39 |
| Close: | 18.33 - 18.53 | 18.53 - 18.7 |
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Mon, 21 Sep 2026
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) - globenewswire.com
Mon, 21 Sep 2026
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law - mykxlg.com
Mon, 21 Sep 2026
Long-Term Shareholders of PROCEPT BioRobotics Corporation - globenewswire.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 57 (M) |
| Shares Float | 56 (M) |
| Held by Insiders | 3.2 (%) |
| Held by Institutions | 100.4 (%) |
| Shares Short | 7,710 (K) |
| Shares Short P.Month | 7,750 (K) |
| EPS | -1.96 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.94 |
| Profit Margin | -32.6 % |
| Operating Margin | -32.1 % |
| Return on Assets (ttm) | -14.8 % |
| Return on Equity (ttm) | -30.3 % |
| Qtrly Rev. Growth | 19.2 % |
| Gross Profit (p.s.) | 3.75 |
| Sales Per Share | 5.92 |
| EBITDA (p.s.) | -1.94 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -74 (M) |
| Levered Free Cash Flow | -49 (M) |
| PE Ratio | -9.5 |
| PEG Ratio | 0 |
| Price to Book value | 3.11 |
| Price to Sales | 3.12 |
| Price to Cash Flow | -14.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|